2JP5 - Header Asymmetric Unit

HEADER PROTEIN BINDING INHIBITOR 20-APR-07 2JP5

TITLE ATWLPPR AN ANTI-ANGIOGENIC PEPTIDE

COMPND MOL_ID: 1; COMPND 2 MOLECULE: ATWLPPR PEPTIDE; COMPND 3 CHAIN: A; COMPND 4 ENGINEERED: YES

SOURCE MOL_ID: 1; SOURCE 2 SYNTHETIC: YES

KEYWDS PEPTIDE, PROTEIN BINDING INHIBITOR

EXPDTA SOLUTION NMR

NUMMDL 20

AUTHOR S.BADACHE,N.C.BOUCHEMAL,C.L.M.HERVE DU PENHOAT

REVDAT 2 24-FEB-09 2JP5 1 VERSN REVDAT 1 04-MAR-08 2JP5 0

JRNL AUTH A.STARZEC,P.LADAM,R.VASSY,S.BADACHE,N.BOUCHEMAL, JRNL AUTH 2 A.NAVAZA,C.H.DU PENHOAT,G.Y.PERRET JRNL TITL STRUCTURE-FUNCTION ANALYSIS OF THE ANTIANGIOGENIC JRNL TITL 2 ATWLPPR PEPTIDE INHIBITING VEGF(165) BINDING TO JRNL TITL 3 NEUROPILIN-1 AND MOLECULAR DYNAMICS SIMULATIONS OF JRNL TITL 4 THE ATWLPPR/NEUROPILIN-1 COMPLEX JRNL REF PEPTIDES V. 28 2397 2007 JRNL REFN ISSN 0196-9781 JRNL PMID 17983687 JRNL DOI 10.1016/J.PEPTIDES.2007.09.013

REMARK 1

REMARK 2 REMARK 2 RESOLUTION. NOT APPLICABLE.

REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : DYANA 1.5 REMARK 3 AUTHORS : GUNTERT, BRAUN AND WUTHRICH REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL

REMARK 4 REMARK 4 2JP5 COMPLIES WITH FORMAT V. 3.15, 01-DEC-08

REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 03-MAY-07. REMARK 100 THE RCSB ID CODE IS RCSB100113.

REMARK 210 REMARK 210 EXPERIMENTAL DETAILS REMARK 210 EXPERIMENT TYPE : NMR REMARK 210 TEMPERATURE (KELVIN) : 298; 278 REMARK 210 PH : 7.0; 7.0 REMARK 210 IONIC STRENGTH : 0.140; 0.140 REMARK 210 PRESSURE : AMBIENT; AMBIENT REMARK 210 SAMPLE CONTENTS : 1 MM ATWLPPR [13C, 15N], 10 REMARK 210 MM PHOSPHATE (THE MIXTURE OF REMARK 210 NA2HPO4 AND NAH2PO4 THAT GAVE REMARK 210 A PH OF 7.0), 140 MM NACL, 5 REMARK 210 MICROMOLAR EDTA, 2 MICROMOLAR REMARK 210 NAN3, 100% D2O; 1 MM ATWLPPR REMARK 210 [13C, 15N], 10 MM PHOSPHATE REMARK 210 (THE MIXTURE OF NA2HPO4 AND REMARK 210 NAH2PO4 THAT GAVE A PH OF 7.0) REMARK 210 , 140 MM NACL, 5 MICROMOLAR REMARK 210 EDTA, 2 MICROMOLAR NAN3, 90% REMARK 210 H2O/10% D2O REMARK 210 REMARK 210 NMR EXPERIMENTS CONDUCTED : 1D 1H SPECTRUM, 2D 1H-13C REMARK 210 HSQC, 2D DQF-COSY, 2D 1H-1H REMARK 210 NOESY, 2D 1H-1H COSY, 3D 1H- REMARK 210 15N TOCSY REMARK 210 SPECTROMETER FIELD STRENGTH : 500 MHZ REMARK 210 SPECTROMETER MODEL : UNITYPLUS REMARK 210 SPECTROMETER MANUFACTURER : VARIAN REMARK 210 REMARK 210 STRUCTURE DETERMINATION. REMARK 210 SOFTWARE USED : PROSA, XEASY 1.3, DYANA 1.5 REMARK 210 METHOD USED : SIMULATED ANNEALING REMARK 210 REMARK 210 CONFORMERS, NUMBER CALCULATED : 100 REMARK 210 CONFORMERS, NUMBER SUBMITTED : 20 REMARK 210 CONFORMERS, SELECTION CRITERIA : STRUCTURES WITH THE LEAST REMARK 210 RESTRAINT VIOLATIONS REMARK 210 REMARK 210 BEST REPRESENTATIVE CONFORMER IN THIS ENSEMBLE : 1 REMARK 210 REMARK 210 REMARK: NMR CHEMICAL SHIFT LIST AT 25 DEGREES C IS GIVEN BUT REMARK 210 THE RESTRAINTS WERE ESTABLISHED AT 5 DEGREES C DUE TO A MORE REMARK 210 FAVORABLE OVERALL TUMBLING AT LOWER TEMPERATURE

REMARK 215 REMARK 215 NMR STUDY REMARK 215 THE COORDINATES IN THIS ENTRY WERE GENERATED FROM SOLUTION REMARK 215 NMR DATA. PROTEIN DATA BANK CONVENTIONS REQUIRE THAT REMARK 215 CRYST1 AND SCALE RECORDS BE INCLUDED, BUT THE VALUES ON REMARK 215 THESE RECORDS ARE MEANINGLESS.

REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 1 TRP A 3 85.29 47.69 REMARK 500 2 TRP A 3 85.36 47.81 REMARK 500 3 TRP A 3 85.39 48.23 REMARK 500 4 TRP A 3 85.46 45.60 REMARK 500 5 TRP A 3 85.42 45.98 REMARK 500 6 TRP A 3 85.35 44.14 REMARK 500 7 TRP A 3 85.32 44.38 REMARK 500 8 TRP A 3 85.47 44.48 REMARK 500 9 TRP A 3 85.33 45.88 REMARK 500 10 TRP A 3 85.35 46.02 REMARK 500 11 TRP A 3 85.35 50.68 REMARK 500 12 TRP A 3 85.34 49.53 REMARK 500 13 THR A 2 170.76 58.87 REMARK 500 13 TRP A 3 85.35 47.93 REMARK 500 14 THR A 2 170.64 58.85 REMARK 500 14 TRP A 3 85.42 50.62 REMARK 500 15 THR A 2 170.69 58.86 REMARK 500 15 TRP A 3 85.32 50.93 REMARK 500 16 THR A 2 170.73 58.88 REMARK 500 16 TRP A 3 85.37 49.14 REMARK 500 17 THR A 2 170.72 58.91 REMARK 500 17 TRP A 3 85.32 50.48 REMARK 500 18 THR A 2 170.74 58.94 REMARK 500 18 TRP A 3 85.29 50.80 REMARK 500 19 THR A 2 170.73 57.01 REMARK 500 19 TRP A 3 85.30 45.71 REMARK 500 20 THR A 2 170.78 57.01 REMARK 500 20 TRP A 3 85.36 48.69 REMARK 500 REMARK 500 REMARK: NULL

REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 15220 RELATED DB: BMRB

REMARK 999 REMARK 999 SEQUENCE REMARK 999 THE AUTHORS STATE THAT THE AMINO ACID SEQUENCE WAS CHOSEN REMARK 999 BY ANALOGY WITH THE VASCULAR ENDOTHELIAL GROWTH FACTOR REMARK 999 (VEGF) SEQUENCE.

DBREF 2JP5 A 1 7 PDB 2JP5 2JP5 1 7

SEQRES 1 A 7 ALA THR TRP LEU PRO PRO ARG

CRYST1 1.000 1.000 1.000 90.00 90.00 90.00 P 1 1

ORIGX1 1.000000 0.000000 0.000000 0.00000

ORIGX2 0.000000 1.000000 0.000000 0.00000

ORIGX3 0.000000 0.000000 1.000000 0.00000

SCALE1 1.000000 0.000000 0.000000 0.00000

SCALE2 0.000000 1.000000 0.000000 0.00000

SCALE3 0.000000 0.000000 1.000000 0.00000